TG Therapeutics
Utility Patent Applications
Last updated:
List of all TG Therapeutics patents 4 in total
| Status | Patent |
|---|---|
Application | Utility: TRIPLE COMBINATION TO TREAT B-CELL MALIGNANCIES Filling date: 7 Sep 2025 Issue date: 12 May 2022 |
Application | Utility: COMBINATION OF ANTI-CD20 ANTIBODY, P13 KINASE-DELTA SELECTIVE INHIBITOR, AND BTK INHIBITOR TO TREAT B-CELL PROLIFERATIVE DISORDERS Filling date: 7 Sep 2025 Issue date: 10 Jun 2021 |
Application | Utility: Combination of Anti-CD20 Antibody and PI3 Kinase Selective Inhibitor Filling date: 7 Sep 2025 Issue date: 15 Oct 2020 |
Application | Utility: COMBINATION OF AN ANTI-CD20 ANTIBODY, PI3 KINASE-DELTA INHIBITOR, AND ANTI-PD-1 OR ANTI-PD-L1 ANTIBODY FOR TREATING HEMATOLOGICAL CANCERS Filling date: 7 Sep 2025 Issue date: 15 Aug 2019 |
Showing 1 to 4 of 4 patents.